You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

340 Results
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    fulvestrant
Aug 2025
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
New Drug Funding Program
    Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant
ODB - General Benefit
    dexamethasone
Apr 2025
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
New Drug Funding Program
    Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant
ODB - General Benefit
    dexamethasone
Sep 2025
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Aug 2025
Drug
Other Name(s): Tecvayli®
Oct 2025
Drug
Other Name(s): Columvi®
Oct 2025
Drug
Other Name(s): Elrexfio™
Sep 2025
Drug
Other Name(s): Blincyto®
Nov 2025
Drug
Other Name(s): Vyloy®
Sep 2025
Drug
Other Name(s): Jemperli
Feb 2025
Drug
Other Name(s): Tecentriq® SC
Jul 2025
Drug
Other Name(s): Keytruda®
Sep 2025

Pages